Canada markets close in 5 hours 41 minutes

Hansoh Pharmaceutical Group Company Limited (3KY.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.08000.0000 (0.00%)
As of 03:29PM CEST. Market open.
Full screen
Previous Close2.0800
Open2.1600
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's Range2.0800 - 2.1600
52 Week Range1.1100 - 2.1600
Volume500
Avg. Volume36
Market Cap12.365B
Beta (5Y Monthly)0.56
PE Ratio (TTM)29.71
EPS (TTM)0.0700
Earnings DateMar 26, 2024
Forward Dividend & Yield0.03 (1.22%)
Ex-Dividend DateJun 19, 2024
1y Target EstN/A
  • GlobeNewswire

    SCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China

    JERSEY CITY, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that China’s National Medical Products Administration (NMPA) has accepted for review a New Drug Application (NDA) for oral ibrexafungerp tablets for the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis (VVC) in the Chinese mainland.